Humacyte Inc. Warrant (HUMAW) at a glance
Humacyte Inc. Warrant (HUMAW) is a Healthcare company. It trades at $0, with a -376.1% profit margin and revenue decline of 4.3%. It pays a 4039.4% dividend yield. Vestovix scores it 43/100 overall. Its strongest dimension is Income (92/100) and its weakest is Safety (12/100). It carries above-market volatility, so expect larger swings.
- Price
- $0.00
- Market cap
- n/a
- P/E ratio
- n/a
- Dividend yield
- 4039.41%
- Beta
- 2.46
- 52-week range
- $0.00 to $0.40
Value
48
Growth
34
Income
92
Safety
12
Momentum
12
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,151.40-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$270.27+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$263.98-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$375.83-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$147.17-0.98%
2.79% yield
ABT54
Abbott Laboratories
$102.23+0.92%
2.16% yield
AMGN65
Amgen Inc.
$379.76-1.05%
2.76% yield